At the 61st ASH Annual Meeting & Exposition, Corey Cutler, Dana Farber Cancer Institute, discusses his presentation: The Evolving Treatment Landscape for Patients with GvHD: More Options, More Decisions, Better Outcomes!
Questions
1. What are the major challenges in the treatment of patients with graft-versus-host disease (GvHD)? (0:05)
2. How have recent advances in understanding of the biology of GvHD impacted on patient management? (0:45)
3. What do you consider the most important emerging therapies for GvHD? (1:22)
4. What do healthcare professionals need to know in terms of monitoring and appropriate management of treatment-related adverse events? (1:54)
5. What other key messages of this symposium would you like to highlight? (2:33)
Corey Cutler has no conflicts of interest to declare in relation to this video.
Filmed at the 61st ASH Annual Meeting & Exposition 2019, Orlando, FL, USA.
